We previously reported that the diverse measurable activities of HF are mediated by an on-target mechanism consisting of inhibiting the glutamyl-prolyl-tRNA synthetase resulting in GCN2 activation (Pitera et al., 2022). The gene discussed is EIF2AK4; the disease is hydrops fetalis.